Dr Agarwal’s Healthcare IPO is now open for subscription, with a price range of Rs 382-402 per share. Despite a significant OFS component and rich pricing, analysts recommend investing for the long term. The company commands a 25% market share in India’s eye care service market, benefiting from industry growth projections.
Rs 23,000 crore outflows! Is the September FII rout indicating a worse end to 2026?
Foreign investors have resumed selling Indian equities in September, with FPI outflows crossing Rs 23,000 crore through September 19. Higher crude prices, elevated US bond